Essential Premium Newsletter Institutional Investor stories focused on hedge funds and alternatives. December 31, 2023 This email is sent out twice a week and covers hedge fund related topics.View a sample Related Articles With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma Stephen Taub Opinion: Retail Access to Private Markets? Continuation Funds Show Why Caution Is Critical Stephen Deane II Communities on Alternative Investments Sponsored by Fidelity Investments